The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft
暂无分享,去创建一个
F. Giannotti | Y. Chalandon | S. Masouridi-Levrat | F. Simonetta | Y. Beauverd | C. Stephan | A. Mamez | S. Morin | C. De Ramon Ortiz | Marta Fabra Urdiola | Elif Mahne | Maria Mappoura | Thien-An Tran | Christian Ayer | Sarah Noetzlin | Isaline Verdon | T. Tran